Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal.Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
